KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Shares Outstanding (Weighted Average) (2016 - 2026)

Merck has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $2.5 billion for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) fell 2.02% to $2.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Mar 2026, down 2.02% year-over-year, with the annual reading at $2.5 billion for FY2025, 1.18% down from the prior year.
  • Shares Outstanding (Weighted Average) was $2.5 billion for Q1 2026 at Merck, down from $2.5 billion in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $2.5 billion in Q2 2023 and troughed at $2.5 billion in Q1 2026.
  • The 5-year median for Shares Outstanding (Weighted Average) is $2.5 billion (2022), against an average of $2.5 billion.
  • Year-over-year, Shares Outstanding (Weighted Average) grew 0.4% in 2023 and then fell 2.02% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.5 billion in 2022, then rose by 0.2% to $2.5 billion in 2023, then dropped by 0.2% to $2.5 billion in 2024, then dropped by 1.18% to $2.5 billion in 2025, then fell by 1.2% to $2.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Shares Outstanding (Weighted Average) are $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).